Silence Therapeutics (SLN) Total Liabilities: 2023-2025
Historic Total Liabilities for Silence Therapeutics (SLN) over the last 7 years, with Sep 2025 value amounting to $72.7 million.
- Silence Therapeutics' Total Liabilities rose 157.40% to $72.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.7 million, marking a year-over-year increase of 159.22%. This contributed to the annual value of $68.6 million for FY2024, which is 29.60% down from last year.
- Per Silence Therapeutics' latest filing, its Total Liabilities stood at $72.7 million for Q3 2025, which was up 2.32% from $71.1 million recorded in Q2 2025.
- Silence Therapeutics' Total Liabilities' 5-year high stood at $97.5 million during Q4 2023, with a 5-year trough of -$156.8 million in Q1 2024.
- Over the past 3 years, Silence Therapeutics' median Total Liabilities value was $26.6 million (recorded in 2023), while the average stood at -$8.4 million.
- As far as peak fluctuations go, Silence Therapeutics' Total Liabilities soared by 476.44% in 2023, and later crashed by 825.94% in 2024.
- Over the past 5 years, Silence Therapeutics' Total Liabilities (MRQ) stood at -$11.5 million in 2021, then crashed by 125.26% to -$25.9 million in 2022, then skyrocketed by 476.44% to $97.5 million in 2023, then dropped by 29.60% to $68.6 million in 2024, then increased by 6.00% to $72.7 million in 2025.
- Its last three reported values are $72.7 million in Q3 2025, $71.1 million for Q2 2025, and $72.6 million during Q1 2025.